Accelerate biotechnology
News
Congress schedule
Media Gallery

CEO OF THE YEAR, 2018 title awarded to Batavia Biosciences!

We are pleased to announce that Dr. Menzo Havenga has been awarded the title CEO OF THE YEAR 2018- CONTRACT DEVELOPMENT AND MANUFACTURING. The European CEO Awards organization celebrates global business leaders that are making major strides in their respective fields. The organization recognizes product, service, functional, strategic, and managerial innovation in companies and individuals showing commercial insight and market integrity….

Menzo Havenga: Officer in the Order of Oranje-Nassau!

We are very proud that our CEO, Menzo Havenga, has been decorated in the Order of Orange-Nassau for his scientific achievements and his contributions to society. The Order of Orange-Nassau is a civil and military Dutch Royal order of chivalry founded on April 4, 1892. Menzo received the decorations that come with this distinction from…

Public-private consortium to propel Batavia Biosciences’ SATIRN technology for vaccine and antibody manufacturing

Leiden, 22 March 2018 – Leiden University has received a prestigious TTW-grant from the Netherlands Organization for Scientific Research (NWO) to collaborate with private partners ZoBio, and Batavia Biosciences to propel SATIRNTM technology, developed by Batavia Biosciences. The project aims to deliver, amongst others, better influenza vaccines. Under the TTW program, scientists from the partners…

Batavia Biosciences is the most innovative company 2017/2018 in the Netherlands

Brussels, 2 March 2018 – Batavia Biosciences has been selected as most innovative company in the Netherlands during an exclusive event held at the British Residence in Brussels for The European Business Awards, Europe’s largest business competition, sponsored by RSM. The award to Batavia was granted by a panel of independent judges including senior business…

Batavia Biosciences teams up with international consortium to support polio eradication

Leiden, 16 January 2018 – Today Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV). The project, funded by the Bill & Melinda Gates Foundation, has the potential to bolster efforts to sustain a polio-free world after the disease has been…

Menzo Havenga awarded CEO of the year 2017 the Netherlands

We are very proud that the prestigious organization “CEO Monthly” has awarded the title of “CEO of the Year 2017 – Netherlands” to our Chief Executive Officer, Menzo Havenga. Menzo was chosen on merit, and a clear vision and strategy. The selection of CEO of the Year is based on a combination of external votes…

We won FD Gazellen Award 2017!

Yesterday, Batavia Biosciences has been awarded with an FD Gazellen Award 2017 by the leading Dutch financial newspaper, Financieel Dagblad as one of the fastest growing mid-sized companies of the Netherlands. It is the third time we have won a FD Gazellen Award and we hope that many more will follow.

Batavia Biosciences teams up with international gene therapy consortium under Horizon2020 program

An international consortium, headed by the group of Prof. Dr. Frank Staal (Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre) has been awarded a €6 million grant from the European Union to develop a gene therapy procedure for newborns suffering from severe combined immunodeficiency syndrome (SCID). According to Prof. Dr. Frank Staal, the development…

Wouter van Catz is Best Biopharmaceutical CFO

We congratulate our Director Finance, Wouter van Catz with being awarded Best Biopharmaceutical CFO of the Benelux in the Global CFO Excellence Awards 2017. These awards have been established to recognize CFO’s whose efforts give rise to the success of the firm. According to the voters of respected industry partners and CFO Monthly‘s own rigorous in-house…